ClinicalTrials.govpublic full text
The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis
multiple sclerosis, ocrelizumab, wearing-off effect, neurofilament light, extended dosing, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 840681
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.